MedCity News
AUGUST 5, 2022
On the micro level, it’s more prescriptive (i.e., regulatory best practices or good manufacturing practices). For most companies and medtech, in particular, good business practices (GBP) happens on multiple levels. On the macro level, it’s expressed as a set of ethics and principles that govern a company’s conduct.
World of DTC Marketing
JULY 28, 2022
Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. The secretary of the U.S. This idea is overwhelmingly popular with the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
MARCH 31, 2022
Under the bill proposed, Medicare beneficiaries and those insured through private plans would pay no more than $35 for a 30-day insulin prescription, or the lesser of $35 or 25% of the plan’s negotiated price for a 30-day prescription. He says that there are a limited number of manufactures in the U.S., billion to $5.7
Pharmaceutical Technology
JULY 15, 2022
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.
World of DTC Marketing
JULY 8, 2022
prescription drug sales signals that big pharma will do anything to avoid hurting profits. For several years, Humira was the best-selling prescription drug in the world.1 10 No manufacturing, packaging, or distribution of Humira or related inputs occurs in Bermuda. The maneuvers employed by AbbVie to avoid paying U.S.
World of DTC Marketing
JULY 12, 2022
According to The Hill “, a large majority of the public favors allowing the government to negotiate for lower prescription drug prices, according to a new poll that comes as a legislative battle plays out on the issue. Isn’t it time for Congress to finally pass legislation that helps patients?
World of DTC Marketing
OCTOBER 21, 2021
More than $170 million of this spending was for products voluntarily withdrawn by their manufacturers after clinical trials showed that they did not improve overall survival in people with various types of cancer.
Expert insights. Personalized for you.
317 
Let's personalize your content